APA (7th ed.) Citation

S, S., S, D., V, N., S, C., M, L., K, K., . . . BJ, B. (2020). Inhibition of IRF5 hyperactivation protects from lupus onset and severity. The Journal of clinical investigation, 130(12), 6700. https://doi.org/10.1172/JCI120288

Chicago Style (17th ed.) Citation

S, Song, et al. "Inhibition of IRF5 Hyperactivation Protects from Lupus Onset and Severity." The Journal of Clinical Investigation 130, no. 12 (2020): 6700. https://doi.org/10.1172/JCI120288.

MLA (9th ed.) Citation

S, Song, et al. "Inhibition of IRF5 Hyperactivation Protects from Lupus Onset and Severity." The Journal of Clinical Investigation, vol. 130, no. 12, 2020, p. 6700, https://doi.org/10.1172/JCI120288.